Alkermes (NASDAQ:ALKS) reported Q2 EPS of $0.06, $0.05 better than the analyst estimate of $0.01. Revenue for the quarter came in at $276.2 million versus the consensus estimate of $268.2 million.
Alkermes (NASDAQ:ALKS) reported Q2 EPS of $0.06, $0.05 better than the analyst estimate of $0.01. Revenue for the quarter came in at $276.2 million versus the consensus estimate of $268.2 million.